RTC
EXAS

Riverview Trust Company’s Exact Sciences EXAS Stock Holding History

Riverview Trust Company’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-8
Closed -$450 – 678
2024
Q4 		$450 Hold
8
– – ﹤0.01% 810
2024
Q3 		$545 Sell
8
-256
-97% -$14.4K ﹤0.01% 769
2024
Q2 		$11.2K Hold
264
– – 0.01% 606
2024
Q1 		$18.2K Buy
+264
New +$16.7K 0.01% 526
2022
Q2 		– Sell
-186
Closed -$13K – 758
2022
Q1 		$13K Buy
+186
New +$13.6K 0.01% 674

Other funds holding EXAS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Riverview Trust Company's EXAS Position: Q1 2025 in Review

Riverview Trust Company sold out of Exact Sciences (EXAS) in Q1 2025, closing a stake of 8 shares — an estimated $450 sold.

Riverview Trust Company first reported a position in EXAS in Q1 2022 and held it in 5 quarters. The position peaked at $18.2K in Q1 2024. 557 funds tracked by Wall St. Rank hold EXAS as of Q1 2025.

  • Riverview Trust Company reported no remaining Exact Sciences position as of Q1 2025 after selling out during the quarter.
  • Riverview Trust Company sold 8 Exact Sciences shares in Q1 2025, an estimated $450.
  • Riverview Trust Company first reported a position in Exact Sciences in Q1 2022 and held it in 5 quarters.
  • Riverview Trust Company's Exact Sciences position peaked at $18.2K in Q1 2024.
  • 557 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2025.

Based on Riverview Trust Company's 13F filing for Q1 2025, filed 11 Apr 2025.